Adenovirus-mediated CTLA4-IgG gene therapy in orthotopic small intestinal transplantation in rats

Transplant Proc. 2001 Feb-Mar;33(1-2):183-4. doi: 10.1016/s0041-1345(00)01967-9.
No abstract available

MeSH terms

  • Abatacept
  • Adenoviridae / genetics
  • Animals
  • Antigens, CD
  • Antigens, Differentiation / blood
  • Antigens, Differentiation / therapeutic use*
  • B7-1 Antigen / drug effects*
  • CD28 Antigens / drug effects*
  • CTLA-4 Antigen
  • Genetic Therapy / methods*
  • Genetic Vectors / therapeutic use*
  • Graft Rejection / blood
  • Graft Rejection / prevention & control
  • Immunoconjugates*
  • Immunoglobulin G / therapeutic use*
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / therapeutic use*
  • Intestine, Small / transplantation*
  • Male
  • Rats
  • Rats, Inbred Lew

Substances

  • Antigens, CD
  • Antigens, Differentiation
  • B7-1 Antigen
  • CD28 Antigens
  • CTLA-4 Antigen
  • Immunoconjugates
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Abatacept